Showing results (921-930 of 2,005) with videos related to

Sort By:
Pageof 201
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|August 19, 2005
A hierarchical approach to coding chemical, biological and pharmaceutical substancesAnya R Keefe, Joel L Bert, John R Grace, et al.
American Journal of Infection Control|February 22, 2016
Assessing patient and caregiver understanding of and satisfaction with the use of contact isolationPaul Chittick, Shalini Koppisetty, Lia Lombardo, et al.
BMC Family Practice|June 5, 2016
Implementing resources to support the diagnosis and management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) in primary care: A qualitative studyKerin Bayliss, Lisa Riste, Rebecca Band, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 26, 2008
Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorderSan-Yuan Huang, Ming-Teng Lin, Mee-Jen Shy, et al.
American Journal of Epidemiology|February 1, 1990
Diet and histologic types of benign breast disease defined by subsequent risk of breast cancerT G Hislop, P R Band, M Deschamps, et al.
The American Journal on Addictions|August 3, 2018
NGF gene polymorphisms are not associated with heroin dependence in a Taiwanese male populationChang-Chih Tsou, Shin-Chang Kuo, Chun-Yen Chen, et al.
Molecular Cancer Research : MCR|October 18, 2019
A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast CancerVincent T Wu, Boris Kiriazov, Kelsey E Koch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancerV F Semiglazov, E E Topuzov, J L Bavli, et al.
Iscience|January 24, 2022
Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicityEtty Kruzel-Davila, Ira Bavli-Kertselli, Ayala Ofir, et al.
Cancer|May 15, 1986
Clinical trials on adjuvant chemotherapy for breast cancerV F Semiglazov, J L Bavli, V M Moiseyenko, et al.
Pageof 201